Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.

Carolyn A Young,Tim Friede,Francesco Pagnini,Chris Gibbons
DOI: https://doi.org/10.1002/14651858.CD011005.pub2
IF: 8.4
2019-10-03
Cochrane Database of Systematic Reviews
Abstract:Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is terminal, progressive neurological condition for which there are no curative treatments. Among people with ALS/MND, fatigue is a common and debilitating symptom, which is characterised by reversible motor weakness and whole-body tiredness that is only partially relieved by rest. The effectiveness of pharmacological or non-pharmacological treatments for fatigue in ALS/MND is not yet established.
medicine, general & internal
What problem does this paper attempt to address?